Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • clinical research

Tag: clinical research

  • BiotechToday
  • World

Lapatinib, Doramapimod with Remdesivir teamed against COVID-19

bioxone December 1, 2020December 1, 2020 1

Souradip Mallick, National Institute of Technology, Rourkela The emergence of SARS-CoV-2 virus has resulted in a worldwide pandemic killed over 1,368,000 people globally (WHO). Currently, effective treatments to inhibit SARS-CoV-2 morbidity and mortality are not available. The pharmacological screen identified several compounds capable of blocking the in vitro replication of two beta-coronaviruses. Among many ones […]

Read More
  • BiotechToday
  • World

Heart failure in the case of post-menopausal women

bioxone November 30, 2020November 30, 2020

Parnad Basu, Amity University Kolkata Doctors have been saying for a very long time that there is no substitution to exercise if you want to live a healthy life. Often than not we have seen that those who don’t ‘move’ from a place for a very long time are prone to diseases like a heart […]

Read More
  • BiotechToday
  • World

Clinical Chemistry Analyzer in Laboratory Setting

bioxone November 24, 2020November 24, 2020 1

Sagnik Nag, Amity University Kolkata On November 18, 2020, the Medica EasyRA benchtop clinical chemistry analyzer was distributed and serviced by Greensboro-based company, which provides healthcare officials and staff to keep a routine test on blood chemistries to include and check metabolic activity profiles, liver enzymes, proper kidney functioning glucose levels, and cardiovascular tests. These […]

Read More
  • BiotechToday
  • World

FGFR1-targeted kinase inhibitors can now help in treating breast cancer

bioxone November 2, 2020November 2, 2020 1

Camelia Bhattacharyya, Amity University Kolkata Breast cancer, a term which scares most women, a type of cancer which changes the life of a patient even those who are survivors, is a much-studied and researched topic around the globe. The early symptoms might include the appearance of a lump at any portion of the breast, blood […]

Read More
  • BiotechToday
  • World

Multisystem inflammatory syndrome associated with SARS-CoV-2

bioxone November 2, 2020November 1, 2020 2

Sayak Biswas, Amity University Kolkata When we first of think of SARS-CoV-2, the first thing that comes to our mind is the pandemic and the complications caused due to the virus. SARS-CoV-2 is a novel virus and not much is known about its nature, despite the pandemic being in our lives now for close to […]

Read More
  • BiotechToday
  • India

MARK4- One of the key players behind the onset of AD

bioxone October 28, 2020October 28, 2020 1

Avipsha Datta, Department of Biophysics, University of Calcutta Alzheimer’s Disease (AD) is a progressive neurodegenerative disorder that impairs brain function and memory. Neurons degenerate, disrupting the neural networks and thereby destroys our memory and other important motor functions. AD is thought to be caused by the abnormal build-up of proteins aggregates in and around the […]

Read More
  • BiotechToday
  • World

Structural and Functional Inhibition of CHIKV by CHK-124 and CHK-263mAbs

bioxone October 24, 2020October 23, 2020

Souradip Mallick, National Institute of Technology, Rourkela Chikungunya fever is a self-remitting viral illness that is common in tropical countries like Africa and Southeast Asia caused by the Chikungunya virus (CHIKV) (Genus- alphavirus, Family-Togaviridae), single-stranded positive-sense RNA enveloped virus, transmitted to humans by infected Aedes aegypti and Aedes albopictus mosquitoes. International travel is one of the […]

Read More
  • BiotechToday
  • World

Fetus in Fetu analysis by modern Multimode Ultrasound

bioxone October 22, 2020October 21, 2020

Souradip Mallick, National Institute of Technology, Rourkela Fetus in fetu (FIF) has been defined as the presence of one of the twins in the body of the other. It is a condition in which malformed and parasitic fetus is located in the body of the normal fetus. It is very difficult for the radiologist to […]

Read More
  • BiotechToday
  • World

Is the frequent prescription of PPI medicines a boon or a bane?

bioxone October 18, 2020October 18, 2020 4

Husna, Amity University Kolkata Proton pump inhibitors (PPIs) are a class of medicines that work on the cells which are lining the stomach, reducing the production of acid in our stomach. They can treat heartburn and gastric acid reflux by irreversibly binding with the Na+ H+ ATPase located on the surface of gastric parietal cells.PPIs […]

Read More
  • BiotechToday
  • World

High dose of Favipiravir helps prevent SARS-CoV-2 infection in hamsters whereas Hydroxychloroquine fails

bioxone October 13, 2020October 12, 2020

Soumya Sarathi Ganguly, Indian Institute of Technology, Kharagpur Virologists were working on two areas of SARS-CoV-2 research at KU Leuven Rega Institute. In one line developing a vaccine that can prevent infection, and in another line of research, they are thriving in search of existing drugs by which the amount of virus can be reduced […]

Read More

Posts navigation

1 2

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy